|
2,103
|
| 34978 |
atypical M2 polarization
|
|
increases_quantity of
|
CXCL8
|
in macrophages
|
|
19538264
|
Q fever
|
|
2,123
|
| 17454 |
flagellum
|
|
increases_quantity of
|
CXCL8
|
during pulmonary infection
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,144
|
| 17879 |
N-(3-Oxododecanoyl)-HSL
|
|
increases_quantity of
|
CXCL8
|
in bronchial epithelial cells
|
|
20723140
|
Pseudomonas aeruginosa diseases
|
|
2,500
|
| 23296 |
lepA
|
|
increases_quantity of
|
CXCL8
|
|
|
18331590
|
Pseudomonas aeruginosa diseases
|
|
2,519
|
| 23452 |
fliC
|
|
increases_quantity of
|
CXCL8
|
|
| 23453 |
aprA
|
|
decreases_quantity of
|
CXCL8
|
|
|
21901099
|
Pseudomonas aeruginosa diseases
|
|
2,545
|
| 23700 |
p38 MAPK
|
|
increases_expression of
|
CXCL8
|
|
| 23703 |
CEBPB
|
|
increases_expression of
|
CXCL8
|
|
| 23770 |
RELA
|
|
increases_expression of
|
CXCL8
|
|
| 23785 |
CXCL8
|
|
increases_activity of
|
immune response
|
|
|
19064995
|
Pseudomonas aeruginosa diseases
|
|
2,812
|
| 25908 |
exoU
|
|
increases_quantity of
|
CXCL8
|
in respiratory epithelial cells
|
| 25918 |
MAPK cascade
|
|
increases_quantity of
|
CXCL8
|
in respiratory epithelial cells
|
|
16790784
|
Pseudomonas aeruginosa diseases
|
|
2,905
|
| 26636 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL8
|
|
| 26702 |
Miglustat
|
|
decreases_expression of
|
CXCL8
|
up-regulated by P. aeruginosa
|
| 26714 |
Amitriptyline
|
|
decreases_expression of
|
CXCL8
|
up-regulated by P. aeruginosa
|
|
21659660
|
Pseudomonas aeruginosa diseases
|
|
2,906
|
| 26638 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
CXCL8
|
|
| 26727 |
Miglustat
|
|
decreases_expression of
|
CXCL8
|
up-regulated by P. aeruginosa
|
|
21659660
|
Pseudomonas aeruginosa diseases
|
|
3,415
|
| 31692 |
exoS
|
|
decreases_quantity of
|
CXCL8
|
in the culture medium of Caco-2 monolayers
|
| 31700 |
exoS
|
|
increases_expression of
|
CXCL8
|
in the culture medium of Caco-2 monolayers
|
| 31701 |
mucD
|
|
decreases_quantity of
|
CXCL8
|
in the culture medium of Caco-2 monolayers
|
|
21626303
|
Pseudomonas aeruginosa diseases
|
|
3,595
|
| 33642 |
exoU
|
|
increases_expression of
|
CXCL8
|
in human epithelial respiratory and microvascular endothelial cell cultures; analysed by RT-PCR
|
| 33643 |
exoU
|
|
increases_quantity of
|
CXCL8
|
in human epithelial respiratory and microvascular endothelial cell cultures; analysed by ELISA
|
| 33645 |
I-kappaB kinase/NF-kappaB signaling
|
|
increases_expression of
|
CXCL8
|
n human epithelial respiratory and microvascular endothelial cell cultures; analysed by RT-PCR
|
| 33646 |
I-kappaB kinase/NF-kappaB signaling
|
|
increases_quantity of
|
CXCL8
|
n human epithelial respiratory and microvascular endothelial cell cultures; analysed by RT-PCR
|
|
22848596
|
Pseudomonas aeruginosa diseases
|
|
3,653
|
| 34771 |
atypical M2 polarization
|
|
increases_quantity of
|
CXCL8
|
in response to C. burnetii infection
|
|
22711638
|
Q fever
|
|
3,660
|
| 34927 |
atypical M2 polarization
|
|
increases_quantity of
|
CXCL8
|
in macrophages; in response to C. burnetii infection
|
|
18768823
|
Q fever
|
|
3,838
|
| 38566 |
fliC
|
|
increases_quantity of
|
CXCL8
|
in keratinocytes
|
| 38567 |
rhamnolipid
|
NOT |
affects_quantity of
|
CXCL8
|
in keratinocytes
|
|
22500651
|
Pseudomonas aeruginosa diseases
|
|
3,942
|
| 40040 |
F2RL1
|
|
increases_quantity of
|
CXCL8
|
|
|
23311922
|
Pseudomonas aeruginosa diseases
|
|
6,554
|
| 62295 |
lasB
|
|
increases_expression of
|
CXCL8
|
|
| 62296 |
lasB
|
|
increases_quantity of
|
CXCL8
|
|
|
24385476
|
Pseudomonas aeruginosa diseases
|
|
6,556
|
| 62300 |
Pyocyanine
|
|
increases_expression of
|
CXCL8
|
in PMA-differentiated U937 cells
|
| 62327 |
Pyocyanine
|
|
increases_quantity of
|
CXCL8
|
in PMA-differentiated U937 cells
|
|
24499192
|
Pseudomonas aeruginosa diseases
|
|
6,616
|
| 63017 |
Pyocyanine
|
|
increases_expression of
|
CXCL8
|
|
|
20962773
|
Pseudomonas aeruginosa diseases
|
HoPaCI